![Drug manufacturing laboratory equipment](https://www.nortonrosefulbright.com/-/media/images/nrf/thought-leadership/canada/publications/life-sciences-healthcare-lab-equipment.jpg?w=265&revision=355955d3-b814-40be-80c7-63b3ad62cb43&revision=5248910870347387904&hash=1F3BEDB56F2489EB29C4E2FCBDED3656)
Publication
Health Canada identifies lithium-ion batteries, infant bath seats, and water beads as hazards of concern
Health Canada has recently identified three new classes of products that pose a hazard of concern.
Global | Publication | November 2015
On 14 July 2015, representatives of the P5+1 countries (the US, UK, France, China and Russia plus Germany) (reached an agreement with Iran on a “Joint Comprehensive Plan of Action” (JCPOA) regarding Iran’s nuclear programme. The JCPOA contains provisions for the lifting of various sanctions against Iran upon IAEA-verified implementation of agreed nuclear-related measures by Iran.
Subsequently on 31 July 2015, the European Council announced that it has adopted the first legal acts to implement the Joint Comprehensive Plan of Action (JCPOA) (UNSCR 2231 (2015)). The EU has adopted two Regulations that amend Regulation (EU) No 267/2012 which concerns restrictive measures against Iran.
In particular, an exemption has been created which enables competent authorities to authorise, in limited situations, the supply, sale, or transfer of items, materials, equipment, goods and technology, and the provision of any related technical assistance, training, financial assistance, investment, brokering or other services.
Publication
Health Canada has recently identified three new classes of products that pose a hazard of concern.
Publication
An employer’s ability to ask for a sick note when an employee is absent from work due to illness is becoming increasingly curtailed across Canada.
Publication
Since 2022, the Government of Canada has introduced three waves of amendments to the Competition Act (Act), making substantive changes to Canada’s competition laws, with the most recent amendments receiving royal assent on June 20, 2024.
Subscribe and stay up to date with the latest legal news, information and events . . .
© Norton Rose Fulbright LLP 2023